The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy? - Wikidata - awgldk - TriplyDB

The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?

The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?

http://www.wikidata.org/entity/Q37601970

about

Compensatory angiogenesis and tumor refractoriness Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells Notch signalling pathway as an oncogenic factor involved in cancer development Targeting osteosarcoma vasculature with peptide obtained by phage display PlGF-induced VEGFR1-dependent vascular remodeling determines opposing antitumor effects and drug resistance to Dll4-Notch inhibitors.Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility.Notch signaling in cerebrovascular diseases (Review)Notch and its oncogenic activity in human malignancies.

P2860

Q26851916-1362A735-2865-47E4-A932-B71C555C52D2 Q28067753-8CD0C35F-0040-44DD-911C-0F3150B428B1 Q28072977-8E81BAF9-C60A-4F06-AF39-4320870F4C87 Q34721714-BE6E1B96-9B80-4139-B524-EA95195D984A Q36268182-3A3A303E-0832-4941-9852-7DBB834DE734 Q38757723-7E1F92A6-BA40-44EA-A7D0-8420EE141219 Q38940654-E93A3A21-1329-4EC4-B4CE-515B3CA257EE Q45743019-2CD16308-490E-491E-901E-88A49588FFDF

P2860

The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?

http://www.wikidata.org/entity/Q37601970

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?

@en

The Notch ligand Delta-like 4

@nl

type

label

The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?

@en

The Notch ligand Delta-like 4

@nl

prefLabel

The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?

@en

The Notch ligand Delta-like 4

@nl

P1433

Q37601970-91710DCD-D4C5-4713-9A77-A7FC0C42AB78

P1476

Q37601970-B8060091-04E7-46A0-A3B7-940F774E09FA

P2093

Q37601970-3474D486-E60A-4FCD-B36A-6160BF9FC366

Q37601970-DF4AE742-33E1-4913-A37F-354B3BAB2C97

Q37601970-FF27D346-BA72-41D6-92AB-20BFA4BAFD4F

P2860

Q37601970-087DE460-3DDD-4AAF-8F23-138B2231516F

Q37601970-13DE1AF8-FF35-4374-B489-00DB38732BA2

Q37601970-17E35983-FA0B-44B0-BD8D-C5078908C201

Q37601970-281CC58F-F35B-4520-87E2-5073E189AC83

Q37601970-28E145AE-387A-48F7-98E2-5BC8969D9B6F

Q37601970-2E760E1F-DF6B-47F9-BBDB-279CEEC13CC0

Q37601970-31F7530C-2008-423E-A5E9-4D88EB8A0F1F

Q37601970-367D0060-87BF-4671-A8D3-E5CA8C87FDB4

Q37601970-3B81D2C3-75C8-4F59-8452-93852D9019D4

Q37601970-3C95B863-C51A-40A1-ABE2-E6EAF6EB71D2

P304

Q37601970-042C6233-77D1-4942-86B1-73B3D02885F1

P31

Q37601970-619E42F5-473F-46AE-99B4-180BE0510BE7

P356

Q37601970-52DE9BDC-E55C-4C2F-AF88-1911F9CDAF26

P433

Q37601970-8DCDDAFE-1FC5-43E2-B2A4-EC456AE03496

P478

Q37601970-33975CEE-6308-42D9-9F0D-287DE626C753

P50

Q37601970-6644B59E-A287-4BD4-8143-3D51C706BA67

P577

Q37601970-35AE82AC-2E9D-45CC-8066-79A5F18B7CEE

P5875

Q37601970-FD2F77F4-3BAB-4392-B9E9-341CBCF31F8D

P698

Q37601970-32080FA2-84D6-47A7-A2A3-F70A105FF14A

P932

Q37601970-44A08A3A-0253-4722-8554-99DAC41BD00E

P356

P1433

Contemporary oncology

P1476

The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?

@en

P2093

Grażyna Kowalczyk-Ziomek

http://www.w3.org/2001/XMLSchema#string

Krzysztof Helewski

http://www.w3.org/2001/XMLSchema#string

Romuald Wojnicz

http://www.w3.org/2001/XMLSchema#string

P2860

Dll4, a novel Notch ligand expressed in arterial endothelium

Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting

Notch: a key regulator of tumor angiogenesis and metastasis

Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos

Dosage-sensitive requirement for mouse Dll4 in artery development

Normalization of the vasculature for treatment of cancer and other diseases.

Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer

Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function.

Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer.

Role of Notch and its oncogenic signaling crosstalk in breast cancer.

P304

234-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/WO.2013.35588

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Marlena Brzozowa

P577

2013-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260528892

http://www.w3.org/2001/XMLSchema#string

P698

24596507

http://www.w3.org/2001/XMLSchema#string

P932

3934076

http://www.w3.org/2001/XMLSchema#string